Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2025-12-24 @ 5:52 PM
NCT ID:
NCT01405768
Eligibility Criteria:
Inclusion Criteria:
* antecedent biopsy read as
* cervical intraepithelial neoplasia (CIN) grade 2 or 3 or microinvasive cancer
* adenocarcinoma in situ
* persistent CIN 1
* antecedent pap read as
* high grade squamous intraepithelial lesion
* atypical glandular cells
* persistent low grade squamous intraepithelial lesion
Exclusion Criteria:
* anatomy unsuitable for safe office loop excision based on operator judgement
* inability to tolerate procedure under local anesthesia
* pregnancy
* age less than 18 years
* inability to understand spoken or written English
* refusal of consent
* prisoner
* mental incapacity
* anticoagulant or antiplatelet therapy, or known bleeding diathesis
* use of analgesics other than over the counter medications(OTC meds include NSAIDS or Tylenol) within 7 days of scheduled LEEP
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01405768
Study Brief:
Protocol Section:
NCT01405768